Aust J Gen Pract 2020 04;49(4):194-199
MBBS, MSc, FRACS, MHE, Senior Staff Specialist Neurosurgeon, Kenneth G Jamieson Department of Neurosurgery, Royal Brisbane and Women@s Hospital, Qld; Associate Professor, University of Queensland, Qld.
Background: Despite their rarity, primary tumours of the central nervous system have a devastating impact on patient survival and quality of life. The classification of glial tumours has recently changed, and large trials have provided data on treatment impact; however, the treatment armamentarium remains the same, and many questions persist.
Objective: The aim of this narrative review is to discuss the current understanding and management of the most common glial brain tumours to equip general practitioners (GPs) and other non-neuro-oncological specialists with appropriate knowledge to share care and support patients.
Discussion: Treatment of brain tumours is complex and multifaceted, and it involves many different specialists. Recent advances in translational research and molecular understanding of brain tumours raise hope that new treatments are imminent, and patients should be encouraged to participate in clinical trials. The GP has an important role in patient support and coordination of care.